Company / Capital Expenditures
Vera Therapeutics, Inc. Capital Expenditures History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$630.0K
FY2025
5-year range
$0 / $972.0K
FY2021-FY2025
Trend
-35.2%
vs FY2024
Sector context
#134 of 194
Health Care
What the data says
At $630,000, Vera Therapeutics, Inc.'s capital expenditures ranks #134 of 194 in the Health Care sector. Improved from $63,000 to $630,000 over the past 2 years.
Based on SEC 10-K filings.
$630,000 in FY2025 with a 5-year CAGR of +44.8%.
Improved from $63,000 to $630,000 over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +116.6%
- 5-Year CAGR
- +44.8%
- 10-Year CAGR
- -
Sector benchmark
#134 of 194 in Health CareTop 69% of 194This company $630.0K Sector average $117.5M
▼
-99.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +44.8%, indicating consistent growth.
- In FY2025, capital expenditures decreased 35.2% year-over-year.
- Ranks #134 out of 194 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $630.0K | -35.2% |
| FY2024 | $972.0K | +1442.9% |
| FY2023 | $63.0K | +1.6% |
| FY2022 | $62.0K | - |
| FY2021 | $0 | -100.0% |
| FY2020 | $99.0K | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026